New Delhi, India

Indu Bhushan


Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Indu Bhushan: Innovator in Pharmaceutical Formulations

Introduction

Indu Bhushan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bioavailable oral dosage forms. With a total of 3 patents to his name, Bhushan's work has the potential to enhance the efficacy of medication delivery.

Latest Patents

Indu Bhushan's latest patents include innovative processes for the preparation of cefuroxime axetil formulations. One of his key inventions is a process for the preparation of a bioavailable oral dosage form of cefuroxime axetil. This invention involves mixing crystalline cefuroxime axetil with amorphous cefuroxime axetil to create a dosage form that contains between 7 to 25% crystalline cefuroxime axetil. Another significant patent is for a bioavailable oral dosage form of cefuroxime axetil, which also comprises amorphous cefuroxime axetil with the same percentage of crystalline content.

Career Highlights

Indu Bhushan is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in pharmaceutical formulations. His work focuses on improving the bioavailability of medications, which is crucial for effective treatment outcomes.

Collaborations

Indu has collaborated with several professionals in his field, including Jitendra Krishan Somani and Himadri Sen, who contribute to the research and development efforts at Ranbaxy Laboratories.

Conclusion

Indu Bhushan's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug delivery systems. His patents reflect a deep understanding of formulation science, which is vital for improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…